Gut Microbiome
‘Adding a cup of beans’ to diet boosts gut microbiome diversity in high-risk obesity, CRC
Adding one cup of navy beans to the usual diet of individuals with obesity and a history of colorectal cancer improved gut microbiome diversity and regulated metabolites and markers related to disease, according to research in eBioMedicine.
‘The future is here’: New products join armamentarium for C. difficile
Clostridioides difficile infection presents a unique treatment paradox for clinicians: Antibiotics are often both its cause and its cure.
Q&A: DIY fecal microbiota transplantation a risky game of ‘Russian roulette’
Despite the availability of fecal microbiota transplantation and FDA-approved live biotherapeutics for recurrent Clostridioides difficile infection, some patients have turned to risky “homebrew” methods to correct their gut microbiome.
‘On the cusp’ of something big: New insights into the microbiome’s role in immunity
As of just a few years ago, early enthusiasm over the apparent interplay between the gut microbiome and the immune system, and that it was driving or exacerbating certain rheumatic diseases, seemed to have all but dried up.
Nutrition, stress reduction can affect women’s health conditions through gut health
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, continues her conversation with Audrey Fleck, MS, RDN, about associations between gut dysbiosis — an unhealthy imbalance of microbes in the gut — and diseases associated with reproductive hormones.
VIDEO: ‘Future is now here’ for recurrent C. difficile, thanks to live biotherapeutics
VANCOUVER, British Columbia — In this Healio video exclusive, Paul Feuerstadt, MD, FACG, AGAF, discusses the evolution of treatment for Clostridioides difficile infection, from antimicrobials to recently FDA-approved live biotherapeutics.
VIDEO: Rebyota ‘not only shuts down recurrence,’ also affects quality of life in C. diff
VANCOUVER, British Columbia — In this Healio video, Paul Feuerstadt, MD, FACG, AGAF, discusses data that link health-related quality of life and microbiome composition among patients with recurrent Clostridioides difficile infection.
Gut microbiome associated with precancerous lesions, future onset of colorectal cancer
The gut microbiome is linked to preexisting colorectal lesions, as well as future development of lesions, according to a presenter at UEG Week, and including microbiome biomarkers may improve noninvasive tests for colorectal cancer.
Top in women’s health: Importance of breast cancer screening access, early treatment
Women with less access to mammogram screening and women with obesity had higher breast cancer mortality rates, according to a study published in JAMA Network Open.
FMT future ‘still being written,’ ideally with more options for recurrent C. difficile
From the early days of homemade “poop shakes” blended in a backroom 15 years ago to the current world of FDA-approved live biotherapeutic products, it feels like we are at an inflection point with fecal microbiota transplantation.